Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.33 |
| ▸ | THRA | P10827 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26373625 | 0.86 | ESR1 (0.37) | ESR1TBXAS1THRATHRB | |
| SCHEMBL25762805 | 0.81 | ESR1 (0.38) | ESR1THRATHRB | |
| SCHEMBL14048418 | 0.79 | TBXAS1 (0.35) | TBXAS1 | |
| SCHEMBL19274923 | 0.77 | ESR1 (0.38) | ESR1THRATHRB | |
| SCHEMBL24297779 | 0.76 | GABRA1 (0.40) | ESR1TBXAS1 | |
| SCHEMBL18573477 | 0.76 | ALDH1A1 (0.53) | ESR1 | |
| SCHEMBL21160601 | 0.76 | ESR1 (0.34) | ESR1 | |
| SCHEMBL13713801 | 0.75 | BCL2L1 (0.44) | — | |
| SCHEMBL26181644 | 0.72 | ESR1 (0.43) | ESR1THRATHRB | |
| SCHEMBL21160607 | 0.71 | ESR1 (0.33) | ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212207-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-07-06 | — | — | US | disclosed |
| US-20230212207-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-07-06 | — | — | US | disclosed |
| US-10629828-B2 | Organic electroluminescence device | UDC IRELAND LIMITED (IE) | 2020-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212207-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OTC, OCIAD1 | ESR1 465/4885TBXAS1 1633/4885THRA 4145/4885 |
| US-10629828-B2 | Organic electroluminescence device | L1CAM, APOL1, MT-ND4L | ESR1 800/4885TBXAS1 3527/4885THRA 4582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.